Search Results - Woo P

Experience of one UK site presenting a closer examination of safety and efficacy of Anakinra (Kineret^®) in systemic juvenile idiopathic arthritis by Livermore P, Woo P

Connect to this object online.

Outcome of repeat dosing of sJIA patients with tocilizumab in one UK centre by Livermore P, Woodworth T, Woo P

Connect to this object online.

An in-depth analysis of young people's experience of their juvenile idiopathic arthritis (JIA) once receiving Etanercept by Livermore P, Woo P, Wedderburn LR

Connect to this object online.

Gene expression in active systemic JIA after anti-IL1 and anti-IL6R treatment by Ogilvie EM, Samuel JM, Woo P

Connect to this object online.

Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with meth... by Hirani SP, Kassoumeri L, Mulligan K, Ruperto N, Woo P, Wedderburn LR, Newman SP

Connect to this object online.

Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA) by Hirani SP, Kassoumeri L, Etheridge A, Mulligan K, Ruperto N, Woo P, Wedderburn L, Newman SP

Connect to this object online.

2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic J... by Ruperto N, Quartier P, Wulffraat N, Woo P, Loy A, Mouy R, Bader-Meunier B, Prakken B, Noseda E, Rordorf C

Connect to this object online.

Prevalence of monogenic autoinflammatory diseases among Pediatric Rheumatology centers: the Eurofever PReS/PRINTO survey by Gattorno M, Frenkel J, Ozen S, De Benedetti F, Konè-Paut I, Neven N, Girschick H, Özdogan H, Wouters C, Woo P, Hofer M, Dolezalova P, Toplak N, Richard V, Martini A, Ruperto N

Connect to this object online.

2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatme... by Ruperto N, Lovell DJ, Cuttica R, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Davidson J, Foeldvari I, Imundo L, Simonini G, Oppermann J, Shen YK, Visvanathan S, Fasanmade A, Mendelsohn A, Martini A, Giannini EH

Connect to this object online.

Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data by Espada G, Pardeo M, Chaitow J, Brown D, Allen R, Zulian F, Zuber Z, Wulffraat N, Joos R, Dolezalova P, Burgos-Vargas R, Woo P, Schneider R, Ruperto N, Brunner H, De Benedetti F, Flato B, Gerloni V, Horneff G, Wright S, Kenwright A, Lovell D, Martini A

Connect to this object online.

The Eurofever Registry for autoinflammatory diseases: results of the first 15 months of enrolment by Touitou I, Woo P, Lachmann H, Dolezalova P, Rose C, Hentgen V, Wouters C, Vesely R, Stojanov S, Simon A, Arostegui J, Kummerle-Deschner J, Ozdogan H, Neven B, Girschick H, Kone-Paut I, Hofer M, De Benedetti F, Ozen S, Frenkel J, Toplak N, Martini A, Ruperto N, Gattorno M

Connect to this object online.